1. Denmark Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Novo Nordisk A/S Class B

Novo Nordisk A/S Class B

27.79
BRL
+0.39
(+1.42%)
2.52EPS
9.74P/E
862.87BMarket Cap
Feb 03Next Earn

Novo Nordisk A/S Class B Documents

Q4 FY2025 · Interim report

Novo Nordisk - Q4 2025 - Interim Report · February 3, 2026 · 43 pages

Read Novo Nordisk A/S Class B's results firsthand

Preview the first 2 pages of this interim report
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents

Annual report

Form 20-F · 43 pages

Feb 4, 2026

Annual report

137 pages

Feb 4, 2026

Interim report

Novo Nordisk - Q4 2025 - Interim Report

43 pages

Feb 4, 2026

Interim report

Novo Nordisk - Q4 2025 - Interim Report

43 pages

Feb 3, 2026

Presentation 1

121 pages

Presentation 2

5 pages

Presentation 3

5 pages

Presentation 4

AGM 2026 FINAL PRESENTATION 26 MAR

51 pages

Presentation 5

121 pages

Press release

4 pages

Q4 FY2025 earnings call →